Economic burden of diabetes in Brazil in 2014

[1]  L. Bahia,et al.  Private health plans with limited coverage: the updated privatizing agenda in the context of Brazil's political and economic crisis. , 2016, Cadernos de saude publica.

[2]  M. Ferraz,et al.  [In hospital care for diabetic foot: a comparison between the estimated cost and the SUS reimbursement]. , 2008, Arquivos brasileiros de endocrinologia e metabologia.

[3]  M. Gomes,et al.  The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[4]  A. Lopes,et al.  Brazilian Chronic Dialysis Census 2014. , 2016, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

[5]  D. Barreto,et al.  Overview of hemodialysis treatment funded by the Brazilian Unified Health System--An economic perspective. , 2015, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

[6]  N. P. Napalkov,et al.  for the prevention and control of noncommunicable diseases , 1999 .

[7]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[8]  Till Bärnighausen,et al.  The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. , 2017, The lancet. Diabetes & endocrinology.

[9]  Jakeline Ribeiro Barbosa,et al.  Epidemiologia e Serviços de Saúde , 2015 .

[10]  B. D. Saúde..  Plano de Ações Estratégicas para o Enfrentamento das Doenças Crônicas Não Transmissíveis (DCNT) , 2011 .

[11]  M. Toh,et al.  Cost-of-illness studies of diabetes mellitus: a systematic review. , 2014, Diabetes research and clinical practice.

[12]  P. Hogan,et al.  Economic Costs of Diabetes in the U , 2013 .

[13]  Plamen Nikolov,et al.  Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.

[14]  B. Duncan,et al.  Dialysis for end stage renal disease financed through the Brazilian National Health System, 2000 to 2012 , 2014, BMC Nephrology.

[15]  B. Jönsson.  Revealing the cost of Type II diabetes in Europe. , 2002, Diabetologia.

[16]  J Benichou,et al.  A review of adjusted estimators of attributable risk , 2001, Statistical methods in medical research.

[17]  B. Jönsson,et al.  Revealing the cost of Type II diabetes in Europe , 2002, Diabetologia.

[18]  Marc Suhrcke,et al.  The Economic Costs of Type 2 Diabetes: A Global Systematic Review , 2015, PharmacoEconomics.

[19]  B. Duncan,et al.  High prevalence of diabetes and intermediate hyperglycemia – The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) , 2014, Diabetology & Metabolic Syndrome.

[20]  A. Siqueira,et al.  Analysis of the Economic Impact of Cardiovascular Diseases in the Last Five Years in Brazil , 2017, Arquivos brasileiros de cardiologia.

[21]  O. E. G. B. M. D. Planejamento.  Pesquisa nacional por amostra de domicílios: acesso e utilização de serviços de saúde: 2003 , 2005 .

[22]  Gustavo C. Lana,et al.  Trends in mortality due to diabetes in Brazil, 1996–2011 , 2015, Diabetology & Metabolic Syndrome.

[23]  Ian J. Brown,et al.  Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. , 2014, The lancet. Diabetes & endocrinology.

[24]  Mohammed K. Ali,et al.  Disability-Free Life-Years Lost Among Adults Aged ≥50 Years With and Without Diabetes , 2015, Diabetes Care.

[25]  Ping Zhang,et al.  IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes. , 2016, Diabetes research and clinical practice.

[26]  R. Atun,et al.  The Brazilian health system at crossroads: progress, crisis and resilience , 2018, BMJ Global Health.

[27]  Marcos Bossi Ferraz,et al.  Internações por pé diabético: comparação entre o custo direto estimado e o desembolso do SUS , 2008 .

[28]  L. Franco,et al.  Multicenter Study of the Prevalence of Diabetes Mellitus and Impaired Glucose Tolerance in the Urban Brazilian Population Aged 30–69 yr , 1992, Diabetes Care.